CC Diagnostics enters EIT Health Catapult Semifinals

Our selection as one of the 30 groundbreaking start-ups in the 9th edition of the EIT Health Catapult underscores our commitment to advancing women's health through innovative diagnostic solutions. As semifinalists, we will engage in intensive training to refine our business model, enhance investment negotiation skills, and perfect our pitch presentations. This journey culminates in pitching our solutions to a distinguished panel of investors and industry leaders, vying for cash prizes and the opportunity to be showcased on the New York Nasdaq Tower. The EIT Health Catapult has a remarkable track record, with over 272 start-ups supported and more than €1 million in in-kind sponsor prizes awarded. This platform not only accelerates growth but also integrates start-ups into the EIT Health Community of world-leading companies. We are grateful to EIT Health for this opportunity and look forward to the upcoming phases of the program. Our team is dedicated to leveraging this experience to further our mission of revolutionizing diagnostics and improving patient outcomes worldwide. For more information about the EIT Health Catapult program, visit EIT Health Catapult.